scispace - formally typeset
S

Setsuko K. Chambers

Researcher at University of Arizona

Publications -  158
Citations -  7181

Setsuko K. Chambers is an academic researcher from University of Arizona. The author has contributed to research in topics: Ovarian cancer & Cancer. The author has an hindex of 45, co-authored 153 publications receiving 6016 citations. Previous affiliations of Setsuko K. Chambers include Yale University & University of Rochester.

Papers
More filters
Journal ArticleDOI

Adenocarcinoma in situ of the cervix: management and outcome.

TL;DR: Women with adenocarcinoma in situ of the uterine cervix had residual disease in 31% of cases with negative margins in cone biopsies and/or with negative ECCs and in 56% of Cases with positive endocervical margins.
Journal ArticleDOI

Allelic loss in ovarian cancer

TL;DR: The findings indicate that multiple tumor‐suppressor genes for ovarian cancer possibly exist on chromosomes 13q, 17, and/or Xp and provide the basis for the identification of candidate gene(s) associated with ovarian cancer.
Journal ArticleDOI

Glyceraldehyde-3-phosphate dehydrogenase binds to the AU-Rich 3' untranslated region of colony-stimulating factor-1 (CSF-1) messenger RNA in human ovarian cancer cells: possible role in CSF-1 posttranscriptional regulation and tumor phenotype.

TL;DR: The study identified GAPDH as an AUBP abundant in Hey cells, where it binds to CSF-1 ARE that imparts mRNA decay, leading to CSf-1 overexpression and increased metastatic properties seen in ovarian cancer.
Journal ArticleDOI

The multifunctional protein glyceraldehyde-3-phosphate dehydrogenase is both regulated and controls colony-stimulating factor-1 messenger RNA stability in ovarian cancer.

TL;DR: In ovarian cancers, it is found that GAPDH expression is regulated, and it is recognized that one of the many functions of GAPDh is to promote mRNA stability of CSF-1, an important cytokine in tumor progression.
Journal ArticleDOI

Extramammary Paget's Disease of the Vulva

TL;DR: Fourteen patients with extramammary Paget's disease of the vulva treated at Yale-New Haven Medical Center from 1982 through 1993 were reviewed to evaluate the accuracy of methods used to delineate surgical margins and to determine if radical operations or surgical margin status was associated with likelihood of recurrence.